Crocs, Inc. $CROX Stock Purchased by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH lifted its position in Crocs, Inc. (NASDAQ:CROX – Free Report) by 14.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 268,617 shares of the textile maker’s stock after purchasing an additional 34,667 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Crocs were worth $31,511,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. bought a new stake in shares of Crocs in the second quarter worth $561,223,000. Patient Capital Management LLC bought a new position in Crocs in the second quarter valued at about $96,443,000. Himalaya Capital Management LLC bought a new position in Crocs in the fourth quarter valued at about $53,720,000. Bank of America Corp DE lifted its holdings in Crocs by 130.1% in the first quarter. Bank of America Corp DE now owns 342,053 shares of the textile maker’s stock valued at $28,397,000 after acquiring an additional 193,426 shares during the period. Finally, Pacer Advisors Inc. boosted its position in Crocs by 5.7% in the first quarter. Pacer Advisors Inc. now owns 339,478 shares of the textile maker’s stock worth $28,183,000 after purchasing an additional 18,220 shares during the last quarter. 93.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Crocs news, Director Beth Kaplan purchased 885 shares of the company’s stock in a transaction on Tuesday, September 15th. The stock was acquired at an average cost of $112.12 per share, for a total transaction of $99,226.20. Following the purchase, the director directly owned 15,259 shares of the company’s stock, valued at $1,710,839.08. This trade represents a 6.16% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Andrew Rees sold 19,072 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $138.91, for a total value of $2,649,291.52. Following the completion of the transaction, the chief executive officer owned 713,293 shares of the company’s stock, valued at $99,083,530.63. The trade was a 2.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 3.10% of the stock is currently owned by insiders.

Crocs Price Performance

Shares of Crocs stock opened at $124.77 on Friday. The company has a market capitalization of $5.98 billion, a price-to-earnings ratio of 10.78, a PEG ratio of 0.98 and a beta of 1.56. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.94. The stock’s 50-day simple moving average is $121.29 and its 200-day simple moving average is $117.40. Crocs, Inc. has a 52 week low of $73.21 and a 52 week high of $141.28.

Crocs (NASDAQ:CROX – Get Free Report) last released its earnings results on Thursday, July 30th. The textile maker reported $4.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.35 by $0.20. Crocs had a return on equity of 47.75% and a net margin of 14.64%. The firm had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter last year, the business posted ($8.82) earnings per share. The firm’s revenue was up 2.6% on a year-over-year basis. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. As a group, analysts expect that Crocs, Inc. will post 13.95 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CROX. Needham & Company LLC raised their target price on Crocs from $132.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, July 24th. Barclays raised shares of Crocs from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $118.00 to $139.00 in a research report on Thursday. Piper Sandler reiterated an “overweight” rating on shares of Crocs in a research note on Friday, July 31st. Robert W. Baird set a $163.00 price objective on shares of Crocs in a research note on Friday, July 31st. Finally, The Goldman Sachs Group reissued a “sell” rating and issued a $95.00 price objective on shares of Crocs in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Crocs has a consensus rating of “Moderate Buy” and a consensus price target of $141.20.

Check Out Our Latest Analysis on CROX

About Crocs

(Free Report)

Crocs, Inc is a global footwear company best known for its molded clogs made from Croslite, a proprietary material designed to provide lightweight comfort and water resistance. The company’s product portfolio also includes sandals, slides, boots, sneakers and other casual footwear, along with Jibbitz charms and accessories that allow consumers to personalize Crocs shoes.

Founded in 2002, Crocs sells its products through company-operated and partner retail stores, e-commerce websites, wholesale partners and third-party digital marketplaces.

Further Reading

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROX – Free Report).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.